The clinical efficacy of dietary fat restriction in treatment of dogs with intestinal lymphangiectasia
- PMID: 24673630
- PMCID: PMC4238835
- DOI: 10.1111/jvim.12327
The clinical efficacy of dietary fat restriction in treatment of dogs with intestinal lymphangiectasia
Abstract
Background: Intestinal lymphangiectasia (IL), a type of protein-losing enteropathy (PLE), is a dilatation of lymphatic vessels within the gastrointestinal tract. Dietary fat restriction previously has been proposed as an effective treatment for dogs with PLE, but limited objective clinical data are available on the efficacy of this treatment.
Hypothesis/objectives: To investigate the clinical efficacy of dietary fat restriction in dogs with IL that were unresponsive to prednisolone treatment or showed relapse of clinical signs and hypoalbuminemia when the prednisolone dosage was decreased.
Animals: Twenty-four dogs with IL.
Methods: Retrospective study. Body weight, clinical activity score, and hematologic and biochemical variables were compared before and 1 and 2 months after treatment. Furthermore, the data were compared between the group fed only an ultra low-fat (ULF) diet and the group fed ULF and a low-fat (LF) diet.
Results: Nineteen of 24 (79%) dogs responded satisfactorily to dietary fat restriction, and the prednisolone dosage could be decreased. Clinical activity score was significantly decreased after dietary treatment compared with before treatment. In addition, albumin (ALB), total protein (TP), and blood urea nitrogen (BUN) concentration were significantly increased after dietary fat restriction. At 2 months posttreatment, the ALB concentrations in the ULF group were significantly higher than that of the ULF + LF group.
Conclusions and clinical importance: Dietary fat restriction appears to be an effective treatment in dogs with IL that are unresponsive to prednisolone treatment or that have recurrent clinical signs and hypoalbuminemia when the dosage of prednisolone is decreased.
Keywords: Canine; Inflammatory bowel disease; Protein-losing enteropathy.
© 2014 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of American College of Veterinary Internal Medicine.
Figures
References
-
- Willard MD, Helman G, Fradkin JM, et al. Intestinal crypt lesions associated with protein‐losing enteropathy in the dog. J Vet Intern Med 2000;14:298–307. - PubMed
-
- Pollard RE, Johnson EG, Pesavento PA, et al. Effects of corn oil administered orally on conspicuity of ultrasonographic small intestinal lesions in dogs with lymphangiectasia. Vet Radiol Ultrasound 2013;54:390–397. - PubMed
-
- Louvet A, Denis B. Ultrasonographic diagnosis: Small bowel lymphangiectasia in a dog. Vet Radiol Ultrasound 2004;45:565–567. - PubMed
-
- Melzer KJ, Sellon RK. Canine intestinal lymphangiectasia. Compend Contin Educ Vet 2002;24:953–961.
-
- Kull PA, Hess RS, Craig LE, et al. Clinical, clinicopathologic, radiographic, and ultrasonographic characteristics of intestinal lymphangiectasia in dogs: 17 cases (1996–1998). J Am Vet Med Assoc 2001;219:197–202. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
